The Department of Health and Social Care (DH) has updated a Serious Shortage Protocols (SSPs) issued for fluoxetine 30mg capsules and salazopyrin 500mg tablets.
SSP07 issued for Fluoxetine 30mg capsules was previously expected to expire on January 8, but now the end date has been further extended to March 12.
SSP08 issued for Salazopyrin EN-Tabs 500mg was previously expected to expire on January 8, but now it has been further extended to January 22.
| SSP & Product | Current expiry date |
| SSP07: Fluoxetine 30mg capsules | This SSP has been varied – the revised end date for SSP07 is now March 12, 2021 |
| SSP08: Salazopyrin EN-Tabs 500mg | This SSP has been varied – the revised end date for SSP08 is now January 22, 2021 |
The expiry dates of an SSP may be brought forward or extended, and the content may be amended at any time during the life of an SSP.
“Pharmacists should ensure they are using the latest version of an SSP before considering the supply of an alternative product. Reimbursement will be provided for the medicine supplied in accordance with the SSP and not on the originally prescribed medicine,” according to a PSNC update.
The reimbursement price will account for VAT payment. Supply in accordance with the SSP will result in the following fees being paid to the contractor…
- One single activity fee (currently £1.27)
- One SSP fee (£5.35)
![Potential Side Effects of Mounjaro [What You Need to Know]](https://www.pharmacy.biz/media-library/image.jpg?id=54516976&width=1245&height=700&quality=90&coordinates=0%2C29%2C0%2C29)
